Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03004937 · ClinicalTrials.gov registry record · NA

Early Auditory Referral in Primary Care

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
10,000
Enrollment target

NCT03004937: Completed NA study, sponsored by University of Michigan.

NCT03004937 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 10,000 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (613% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03004937, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
10,000 participants
Enrollment target

Study Summary

Busy Primary Care providers (PCPs) have complex practices with many competing demands, making it difficult to improve their HL identification rates. Little research has been conducted to identify effective approaches to address the poor PCP knowledge and provide tools for them to better identify/refer patients with HL for appropriate intervention. Current data suggests there is a critical need to redesign how PCPs deliver hearing health care (HHC) by developing focused educational programs and simple clinical management tools to help them integrate HHC into their practices. To address this need, this study will educate providers on hearing loss (HL) screening/treatment as well as create a Best Practice Alert (BPA), or clinical prompt, that is configured for maximal effectiveness in reminding PCPs to ask their patients if they think they have a HL. This combination of education for providers and clinical reminder could help increase HL screening rates but how much is not clear. This 5 year R21/R33 study funded by National Institute of Deafness and Communicative Disorders seeks to provide detailed understanding of both how educating providers on HL and the use of an effective BPA affects HL screening rates and identification for people with mild to moderate hearing loss.

Primary Outcome

Baseline data on providers and the clinics will be compared to post-intervention data to determine if hearing loss screening referrals improved; Investigators will also do a step-wedged analysis to look at differences between clinics that have gone live with the BPA and those who have not yet gone live.

Interventions

  • OTHER Family Medicine Hearing Loss Best Practice Alert

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2014-04
Est. Completion 2019-03-31
Phase NA
University of Michigan

1,327 total trials

What the finished NCT03004937 record still lists

NCT03004937 is an interventional study that assigns participants to a tested intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (613% higher).

The record links to 0 conditions, and to 1 intervention - of which Family Medicine Hearing Loss Best Practice Alert is the first listed.

NCT03004937 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03004937 about?

NCT03004937 is a clinical study titled "Early Auditory Referral in Primary Care". Busy Primary Care providers (PCPs) have complex practices with many competing demands, making it difficult to improve their HL identification rates. Little research has been conducted to identify effective approaches to address the poor PCP knowledge and provide tools for them to better identify/ref...

What is the current status of trial NCT03004937?

This trial is currently completed. It is a NA study. The enrollment target is 10,000 participants. The study started on 2014-04. Estimated completion is 2019-03-31.

What interventions are being tested in trial NCT03004937?

The interventions under investigation include: Family Medicine Hearing Loss Best Practice Alert (OTHER).

Who is sponsoring clinical trial NCT03004937?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03004937's enrollment target sits among peer trials

10,000 14th of 2000 higher than 1,985 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00160771 · 10,000 participants

    Biomechanics/Motion Analysis Laboratory Data Bank

  • NCT00896935 · 10,000 participants

    Arizona Cancer Center Biospecimen Repository

  • NCT00898235 · 10,000 participants

    Collection of Samples and Clinical Data From Patients With Amyloid Diseases

  • NCT00992303 · 10,000 participants

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03004937, the US trial registry maintained by the National Library of Medicine. NCT03004937 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.